All In Biotech

Drug Trial Radar · NCT03926130

A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease

Last checked: Nov 20, 2026Latest source record: Dec 27, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 1,158 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,158

Actual

Start

Jul 23, 2019

Primary completion

Aug 23, 2023

Study completion Oct 2, 2023

Sponsor

Lead sponsor
Eli Lilly and CompanyEli Lilly (LLY)
Sponsor type
Industry
First posted
Apr 24, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 15 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The reason for this study is to see if the study drug mirikizumab is safe and effective in participants with moderately to severely active Crohn's disease.

Conditions

  • Crohn's Disease

Interventions

  • MirikizumabDrug

    Administered IV

  • MirikizumabDrug

    Administered SC

  • UstekinumabDrug

    Administered IV

  • UstekinumabDrug

    Administered SC

  • PlaceboDrug

    Administered IV

  • PlaceboDrug

    Administered SC

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Adult Participants Achieving Clinical Response at Week 12 and Endoscopic Response at Week 52 (Placebo and Mirikizumab)Time frame: Week 12 to Week 52
  2. Percentage of Adult Participants Achieving Clinical Response at Week 12 and Clinical Remission at Week 52 (Placebo and Mirikizumab)Time frame: Week 12 to Week 52

Locations

580 sites in 34 countries. Site status is shown where the registry gives one.

  • University of Alabama-The Kirklin Clinic

    Birmingham, Alabama

  • Digestive Health Specialists

    Dothan, Alabama

  • Lakeview Clinical Research

    Guntersville, Alabama

  • Care Access Research - Tuscaloosa

    Tuscaloosa, Alabama

  • Research Solutions of Arizona

    Litchfield Park, Arizona

  • Central Arizona Medical Associates, PC

    Mesa, Arizona

  • Arizona Arthritis & Rheumatology Research, PLLC

    Phoenix, Arizona

  • Reliance Research

    Scottsdale, Arizona

  • Synexus Site Network

    Tempe, Arizona

  • inSite Digestive Health Care

    Arcadia, California

  • B G Clinical Research, Inc.

    Encinitas, California

  • Care Access - Gilroy

    Gilroy, California

  • Newport Huntington Med Grp

    Huntington Beach, California

  • Om Research, LLC

    Lancaster, California

  • GastroIntestinal Biosciences Clinical Trials

    Los Angeles, California

  • California Medical Research Associates

    Northridge, California

  • University of California Irvine

    Orange, California

  • inSite Digestive Health Care

    Pasadena, California

  • Care Access Research - San Jose

    San Jose, California

  • Wolverine Clinical Trials, LLC

    Santa Ana, California

  • Fomat Medical Research, Inc.

    Thousand Oaks, California

  • Connecticut Gastroenterology

    Manchester, Connecticut

  • IMR of South Florida

    Aventura, Florida

  • Gastroenterology Consultants of Clearwater

    Clearwater, Florida

  • West Central Gastroenterology d/b/a Gastro Florida

    Clearwater, Florida

  • Inpatient Research Clinic

    Hialeah, Florida

  • Doral Medical Research

    Hialeah, Florida

  • C2 Research Center, LLC

    Jacksonville, Florida

  • I.H.S. Health, LLC

    Kissimmee, Florida

  • Central Florida Gastro Research

    Kissimmee, Florida

  • Florida Research Institute

    Lakewood Rch, Florida

  • Wellness Clinical Research

    Lehigh Acres, Florida

  • Columbus Clinical Services, LLC

    Miami, Florida

  • Infinite Clinical Research

    Miami, Florida

  • Nickalus Children's Hospital Research Institute

    Miami, Florida

  • Research Associates of South Florida, LLC

    Miami, Florida

  • SaludMax Medical Corp

    Miami, Florida

  • Ezy Medical Research

    Miami, Florida

  • Coral Research Clinic Corp

    Miami, Florida

  • Goji Group - Research Trials Group

    Miami Lakes, Florida

Showing 40 of 580 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.